Last updated 2026-07-20
- Raised Pre-Seed round led by aMoon Fund, Aug 2021
Total raised
—
Last: Undisclosed Round 2021-09
Stage
Pre-Seed
Founded
2021
Headcount
5
HQ
Herzliya, Israel
Sector
Health Tech & Life Sciences
About
Sentient Synthetics, formerly Rivas AI, is a Technion (Israel Institute of Technology) spin-off company. It is an AI-based, digital pathology company that leverages cutting-edge machine learning to create synthetic pathology datasets. These datasets aim to overcome existing data limitations in computational pathology by providing validated, affordable, thoroughly labeled, and privacy-free data. This enables faster and more accurate training and validation for highly accurate AI algorithms by medical research centers, digital health, pharma, and diagnostics companies, for all cancer tissue types, including rarer forms.
Funding history · 1 round · — total
2021-08
Pre-Seed
Undisclosed
★ aMoon Fund
Headcount over time
From 7 (2022-01) to 5 (2023-04) · -2 (-29%) · 3 points · source: Finder history + radar grounding
Q&A
- What is Sentient Synthetics' primary focus?
- Sentient Synthetics is an AI-based, digital pathology company that uses machine learning to create synthetic pathology datasets. These datasets aim to overcome data limitations in computational pathology and enable faster, more accurate training and validation for AI algorithms in medical research, digital health, pharmaceutical companies, and diagnostics for various cancer tissue types.
- When was Sentient Synthetics founded?
- Sentient Synthetics was founded in May 2021.
- How much funding has Sentient Synthetics raised to date?
- Sentient Synthetics has raised a total of $250,000.
- Which investor participated in Sentient Synthetics' funding round?
- aMoon Fund participated in Sentient Synthetics' funding round in September 2021.
- What is the current employee count for Sentient Synthetics?
- Sentient Synthetics has 1-10 employees.
- Who are the founders of Sentient Synthetics?
- The founders of Sentient Synthetics include Prof. Yonatan (Yoni) Savir, who serves as Founder & CSO, and Fabian Schvartzman, who serves as Co-founder & CEO.
- What is Sentient Synthetics' current product stage?
- Sentient Synthetics is currently in the R&D product stage.
- What is Sentient Synthetics' primary sector?
- Sentient Synthetics' primary sector is Health Tech & Life Sciences.
Team · 3
Nati Daniel
Founder · Co-Founder
Yonatan Savir
Founder · Co-Founder
Tanya Wasserman
Founder · Co-Founder
Sectors & technology
Primary sector
Health Tech & Life Sciences
Sub-sectors
Health Tech & Life SciencesDigital HealthcareDigital Medical Diagnostics
Technologies
Platforms & InterfacesSoftwareArtificial IntelligenceMachine Learning
Target customers
Enterprise & Professional ServicesHealthcare & Life SciencesLife SciencesPharmaceuticalsHealthcareProviders
Business model
B2B
Tags
enterprise-solutionssynthetic-datadiagnosticspharma-companiessoftware-platformhealthcare-providersmachine-learningartificial-intelligencedigital-healthcarecancer
Full data — links, identifiers, deals & radar signals (jobs, patents, research, more)
External links
| Website | sentient-med.com |
|---|---|
| linkedin.com/company/76520188 |
Identifiers & details
| Legal name | Sentient Med Ltd. |
|---|---|
| Former names | Rivas AI |
| Founded | 2021-5 |
| Employees (exact) | 5 |
Radar intelligence
Web history (Wayback)
| Domain | sentient-med.com |
|---|
Certificate / subdomain footprint
| Subdomains | 1 |
|---|
Israeli Companies Registrar (רשם החברות / ICA)
| Registrar # (ח.פ.) | 516403169 |
|---|---|
| Status | פעילה |
| Corp type | ישראלית חברה פרטית |
| Incorporated | 2021-05-27 |
| Purpose | לעסוק בכל עיסוק חוקי |
| Liability | מוגבלת |
| In violation (unfiled) | no |
| Last annual report | 2025 |
| Active charges / liens | 0 |
| Registry events | 0 |
| Registered address | המדרון 7 הרצליה |